Side Effects of Topiramate
Most Frequent Adverse Effects
- The American Academy of Neurology recommends monitoring for paresthesias, cognitive impairment, fatigue, decreased appetite, nausea, diarrhea, weight loss, and taste disturbances, with paresthesias occurring in 28-51% of patients depending on dose 1
- Mood disturbances, including depression, mood problems, irritability, and nervousness, are reported 1
Gastrointestinal and Metabolic Effects
- Appetite suppression and weight loss occur commonly, which can be beneficial in obesity treatment but requires monitoring 1
- Taste perversion, nausea, diarrhea, and constipation are frequently reported 1
- Dry mouth is a common complaint 1
General Systemic Effects
- Fatigue and sleepiness occur frequently, particularly during dose titration 1
- Insomnia can develop, especially if taken later in the day 1, 2
- Palpitations may occur due to the phentermine component when used in combination therapy 1
Serious Adverse Effects Requiring Immediate Attention
Metabolic Acidosis
- Serum bicarbonate monitoring is mandatory before and periodically during treatment 3
- This risk is particularly elevated in patients with pulmonary pathology 4
Renal Complications
- Kidney stone formation occurs in 1.3-1.5% of patients, representing a 2-4 fold increased risk versus the general population 3
- Adequate hydration is essential to minimize stone formation risk 3
Special Population Considerations
Pregnancy and Teratogenicity
- Female patients of childbearing potential require counseling on contraception and monthly pregnancy testing should be considered 3
Critical Safety Warnings
Discontinuation Protocol
- Never discontinue topiramate abruptly as this can precipitate seizures even in patients taking it for migraine prevention 2
- Taper by taking one capsule every other day for at least 1 week before complete cessation 2, 3
Contraindications
- Absolute contraindications include: cardiovascular disease or uncontrolled hypertension, untreated hyperthyroidism, pregnancy without reliable contraception, and concurrent MAO inhibitor use 1
Drug Interactions
- Avoid use with or within 14 days of MAO inhibitors 3